Welcome to the CDD for Biologics Summit?
Recent advances in data availability and breakthroughs in computational power have given scientists new opportunities to optimise the discovery, design and developability of biotherapeutics.
However, with their utility lacking comparatively behind the small molecule space, there remains an ever-present need to address current capabilities amongst the scientific and operational challenges that exist.
With input from the likes of BMS, MedImmune, EMD Serono, Denali & Kadmon; CDD for Biologics has been specifically designed to help biopharma companies define strategies to further adapt these tools, mitigate data availability issues and address computational-experimental challenges to add immediate value to their biologics pipelines.
Join us, as our expert speaker faculty shares the very latest insights into how these tools are being utilised to enhance cost-effectiveness, shorten biologics development timelines and accelerate program development.
Who Attended Last Year?
See what our delegates and sponsors had to say about CDD for Biologics